The induction of tolerance to alloantigens using HLA-based synthetic peptides

Keyphrases

• Alloantigen 100%
• Antigen-specific 50%
• Clinical Trials 50%
• Immunomodulatory 50%
• Immunosuppression 50%
• Linear Sequence 50%
• Long-term Graft Survival 50%
• MHC Class I 50%
• MHC Class II 50%
• Phenomenology 50%
• Synthetic Peptides 100%
• Unresponsiveness 50%

Immunology and Microbiology

• Alloantigen 100%
• Antigen Specificity 50%
• Immunosuppression 50%